Vivani Medical 株価情報 (NASDAQ: VANI)

最新ニュース Vivani Medical (NASDAQ:VANI) 株価情報

Vivani Medical

Vivani Medical Inc is a preclinical-stage biopharmaceutical company. The company develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division. The Biopharm Division includes activities from NPM and Vivani Medical Australia Pty Ltd, and the Neurostimulation Division includes activities from Cortigent and its subsidiary in Switzerland.

Vivani Medical Inc

Vivani Medical Inc Warrants (14/03/2024)

Vanilla Network

Inseego (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INSG#NASDAQ">INSG</a>) reported quarterly losses of $(0.16) per share which missed the analyst consensus estimate of $(0.08) by 100 percent. This is a 63.64 percent increase over losses of $(0.44) per share from the same period last year. The company reported quarterly sales of $31.67 million which missed the analyst consensus estimate of $32.06 million by 1.20 percent. This is a 29.63 percent decrease over sales of $45.01 million the same period last year.

Earnings

Earnings Misses

News

INSG

Inseego Q1 EPS $(0.16) Misses $(0.08) Estimate, Sales $31.67M Miss $32.06M Estimate

ZipRecruiter (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZIP#NYSE">ZIP</a>) sees Q2 sales of $108.000 million-$114.000 million vs $114.22 million analyst estimate.

Guidance

ZipRecruiter Sees Q2 Sales $108.000M-$114.000M vs $114.22M Est

AVITA Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RCEL#NASDAQ">RCEL</a>) affirms FY2025 sales outlook from $100.00 million-$106.00 million to $100.00 million-$106.00 million vs $102.26 million estimate.

RCEL

AVITA Medical Affirms FY2025 Commercial Revenue Guidance of $100.00M-$106.00M vs $102.26M Est

Mach Natural Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MNR#NYSE">MNR</a>) reported quarterly earnings of $0.31 per share which missed the analyst consensus estimate of $0.63 by 50.79 percent. This is a 29.55 percent decrease over earnings of $0.44 per share from the same period last year. The company reported quarterly sales of $226.77 million which missed the analyst consensus estimate of $254.54 million by 10.91 percent. This is a 5.18 percent decrease over sales of $239.16 million the same period last year.

CORRECTION: Mach Natural Resources Q1 Adj. EPS $0.31 Misses $0.63 Estimate, Sales $226.77M Miss $254.54M Estimate

Varex Imaging (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VREX#NASDAQ">VREX</a>) is looking for Q3 Adj EPS of $(0.05)-$0.10 vs $0.16 analyst estimate. sees sales of $180.000 million-$200.000 million vs $210.00 million analyst estimate.

VREX

Varex Imaging Sees Q3 Adj EPS $(0.05)-$0.10 vs $0.16 Est; Sees Sales $180.000M-$200.000M vs $210.00M Est

Shareholders of UnitedHealth Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) filed a class-action lawsuit on Wednesday accusing the company of misleading investors by concealing the negative business impacts that followed the December 2024 killing of UnitedHealthcare <a href="https://www.benzinga.com/news/legal/25/02/43887520/luigi-mangione-back-in-court-friday-supporters-donate-500k-to-suspected-killer">CEO Brian Thompson.</a>
The Details: The lawsuit alleges UnitedHealth withheld critical information regarding the backlash and regulatory scrutiny that arose after the CEO's death, particularly concerning the company's aggressive claims denial practices.&nbsp;
Read Next: <a href="https://www.benzinga.com/general/travel/25/05/45260938/disneys-new-abu-dhabi-theme-park-will-be-authentically-disney-and-distinctly-emirati-ceo-bob-iger-says?utm_source=articleShare">Disney&#8217;s New Abu Dhabi Theme Park Will Be &#8216;Authentically Disney And Distinctly Emirati,&#8217; CEO Bob Iger Says&nbsp;</a>
According to the plaintiffs, the public outcry and scrutiny forced strategic, more "patient-friendly" changes that would reduce the company's profitability.
UnitedHealth had initially forecasted adjusted earnings per share between $29.50 and $30 for 2025 and reaffirmed this outlook in January 2025, despite mounting public and regulatory pressures.&nbsp;
However, on April 17, 2025, the company revised its 2025 profit forecast downward to a range of $26 to $26.50. UnitedHealth stock plunged 22.4%, wiping out approximately $119 billion in market value in one day.&nbsp;
The shareholders contend UnitedHealth's failure to disclose the shift away from its previously aggressive claim denial strategies and the resulting impact on profitability constituted materially false and misleading statements. 
The lawsuit was filed in federal court in Manhattan and named UnitedHealth executives, including CEO Andrew Witty and CFO John Rex, as defendants. It covers the period from Dec. 3, 2024, to April 16, 2025, and seeks damages for shareholders who purchased UnitedHealth shares during that time.
&#8220;The company denies any allegations of wrongdoing and intends to defend the matter vigorously,&#8221; a UnitedHealthcare spokesperson said in a statement to NBC News.&nbsp;
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/news/legal/25/05/45226604/president-trump-wants-to-reopen-alcatraz-heres-what-it-would-take?utm_source=articleShare">President Trump Wants To Reopen Alcatraz: Here&#8217;s What It Would Take</a></li>
</ul>
Image: Shutterstock

Health Care

Legal

Management

Insurance

General

UnitedHealth Investors Claim Company Hid Profit Impact Of CEO's Murder

Oracle (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>) has outperformed the market over the past 20 years by 5.21% on an annualized basis producing an average annual return of 13.37%. Currently, Oracle has a market capitalization of $422.43 billion. 
Buying $1000 In ORCL: If an investor had bought $1000 of ORCL stock 20 years ago, it would be worth $12,170.04 today based on a price of $150.64 for ORCL at the time of writing.
<h3>Oracle's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1746744319_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

ORCL

Here's How Much $1000 Invested In Oracle 20 Years Ago Would Be Worth Today

Strattec Security (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STRT#NASDAQ">STRT</a>) reported quarterly earnings of $1.50 per share which beat the analyst consensus estimate of $0.95 by 57.89 percent. This is a 305.41 percent increase over earnings of $0.37 per share from the same period last year. The company reported quarterly sales of $144.08 million which beat the analyst consensus estimate of $140.84 million by 2.30 percent. This is a 2.35 percent increase over sales of $140.77 million the same period last year.

Earnings Beats

STRT

UPDATE: Strattec Security Q3 Adj. EPS $1.50 Beats $0.95 Estimate, Sales $144.08M Beat $140.84M Estimate

LPL Finl Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LPLA#NASDAQ">LPLA</a>) reported quarterly earnings of $5.15 per share which beat the analyst consensus estimate of $4.67 by 10.28 percent. This is a 22.33 percent increase over earnings of $4.21 per share from the same period last year. The company reported quarterly sales of $3.67 billion which beat the analyst consensus estimate of $3.27 billion by 12.11 percent. This is a 29.54 percent increase over sales of $2.83 billion the same period last year.

LPLA

CORRECTION: LPL Finl Hldgs Q1 Adj. EPS $5.15 Beats $4.67 Estimate, Sales $3.67B Beat $3.27B Estimate

Affirm Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AFRM#NASDAQ">AFRM</a>) reported quarterly earnings of $0.01 per share which beat the analyst consensus estimate of $(0.03) by 133.33 percent. This is a 102.33 percent increase over losses of $(0.43) per share from the same period last year. The company reported quarterly sales of $783.13 million which beat the analyst consensus estimate of $783.03 million by 0.01 percent. This is a 35.92 percent increase over sales of $576.16 million the same period last year.

AFRM

CORRECTION: Affirm Holdings Q3 EPS $0.01 Beats $(0.03) Estimate, Sales $783.13M Beat $783.03M Estimate

Additionally, the board has authorized a new share repurchase program of up to $1 billion of the company's common shares. This replaces the recently completed $1 billion share repurchase program, which was authorized in September 2021. In the second quarter of 2025, the company executed the remainder of its prior authorization by repurchasing approximately $74 million of common shares. Repurchases under the new program may be made through a variety of methods, including but not limited to open market purchases, unsolicited or solicited privately negotiated transactions, tender offers, block trades, accelerated share repurchase transactions, or pursuant to 10b5-1 trading plans.

Buybacks

Weyerhaeuser Authorizes New $1B Share Repurchase Program

Alcoa Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AA#NYSE">AA</a>, ASX: AAI))) (the "Company" or "Alcoa") announced that its Board of Directors (the "Board") has named Thomas J. Gorman as non-executive Chairmanof the Board, effective today, May 8, 2025, immediately upon the conclusion of the Company's 2025 Annual Meeting of Stockholders. Mr. Gorman has served as an independent director of the Board since May 2021, and succeeds Steven W. Williams in that position, who stepped down from the Board effective today after over eight years of service.

Alcoa Corporation Names Thomas J. Gorman As Board Chairman, Effective today, May 8, 2025

Four Corners Property Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FCPT#NYSE">FCPT</a>), a real estate investment trust primarily engaged in the ownership and acquisition of high-quality, net-leased restaurant and retail properties ("FCPT" or the "Company"), is pleased to announce the acquisition of three Express Oil Change &amp; Tire Engineers properties for $9.5 million. The properties are located in highly trafficked corridors in Georgia and are corporate-operated under long term, triple net leases with approximately 19 years of term remaining. The transaction was priced at a 6.6% cap rate on rent as of the closing date and exclusive of transaction costs.

FCPT

FCPT Announces Acquisition Of 3 Express Oil Change & Tire Engineers Properties For $9.5M

Alnylam Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALNY#NASDAQ">ALNY</a>) has outperformed the market over the past 15 years by 8.93% on an annualized basis producing an average annual return of 20.2%. Currently, Alnylam Pharmaceuticals has a market capitalization of $33.44 billion. 
Buying $100 In ALNY: If an investor had bought $100 of ALNY stock 15 years ago, it would be worth $1,535.06 today based on a price of $258.35 for ALNY at the time of writing.
<h3>Alnylam Pharmaceuticals's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1746743413_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ALNY

$100 Invested In Alnylam Pharmaceuticals 15 Years Ago Would Be Worth This Much Today

Clearfield (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLFD#NASDAQ">CLFD</a>) is looking for Q3 GAAP EPS of $0.01-$0.08 vs $(0.06) analyst estimate. sees sales of $45.000 million-$50.000 million vs $47.88 million analyst estimate.

CLFD

Clearfield Sees Q3 GAAP EPS $0.01-$0.08 vs $(0.06) Est; Sees Sales $45.000M-$50.000M vs $47.88M Est

Clearfield (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLFD#NASDAQ">CLFD</a>) affirms FY2025 sales outlook from $170.00 million-$185.00 million to $170.00 million-$185.00 million vs $177.55 million estimate.

Clearfield Affirms FY2025 Sales Guidance of $170.00M-$185.00M vs $177.55M Est

Cardinal Energy (TSX:<a class="ticker" href="https://www.benzinga.com/stock/CJ#TSX">CJ</a>) reported quarterly earnings of $0.13 per share which missed the analyst consensus estimate of $0.17 by 23.53 percent. This is a 30 percent increase over earnings of $0.10 per share from the same period last year. The company reported quarterly sales of $149.77 million which beat the analyst consensus estimate of $145.10 million by 3.22 percent. This is a 6.80 percent increase over sales of $140.23 million the same period last year.

TSX:CJ

Cardinal Energy Q1 GAAP EPS $0.13 Misses $0.17 Estimate, Sales $149.77M Beat $145.10M Estimate

TKO Group Holdings Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TKO#NYSE">TKO</a>) reported first-quarter financial results after the market close on Thursday. Here&#8217;s a rundown <a href="https://www.benzinga.com/pressreleases/25/05/b45299391/tko-reports-first-quarter-2025-results">of the report</a>.
<ul>
<li>Q1 Revenue: $1.27 billion, versus <a href="http://benzinga.com/quote/TKO/earnings">estimates</a> of $1.10 billion</li>
</ul>
<ul>
<li>Q1 EPS: 69 cents, versus estimates of 56 cents</li>
</ul>
TKO Group, the parent company of Ultimate Fighting Championship (UFC) and World Wrestling Entertainment (WWE), said total revenue increased 4% year-over-year in the first quarter, driven by strength in the UFC and WWE. UFC drove $359.7 million in revenue and WWE revenue came in at $391.5 million.
The company generated cash flows from operations of $162.8 million and free cash flow of $135.5 million in the quarter. TKO Group ended the period with $470.9 million in cash and cash equivalents.
&#8220;TKO is off to a good start in 2025 with both UFC and WWE delivering solid financial results. Given the strength and momentum of these businesses and no material change to our overall business&nbsp;outlook, we are raising our&nbsp;guidance,&#8221; said Ariel Emanuel, executive chair and CEO of TKO Group.
&#8220;Our conviction in our portfolio of assets is strong and we are now focused on integration, driving synergies, the domestic media rights deal for UFC, and our capital return programs.&#8221;
Guidance: TKO Group raised its revenue guidance for full-year 2025 from a range of $2.93 billion to $3 billion to a new range of $3 billion to $3.08 billion. 
Including the impact of the acquisitions under IMG (On Location and Professional Bull Riders) the company expects full-year revenue of $4.49 billion to $4.56 billion.
TKO Price Action: <a href="http://benzinga.com/quote/tko">TKO Group shares</a> were up 0.91% after-hours, trading at $170.50 at the time of publication on Thursday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/sports/25/05/45303072/draftkings-q1-earnings-highlights-revenue-miss-eps-miss-guidance-cut-after-bettors-beat-the-house">DraftKings Q1 Earnings Highlights: Revenue Miss, EPS Miss, Guidance Cut After Bettors Beat The House</a></li>
</ul>
Photo: Delmiro Junior/Shutterstock.

Sports

After-Hours Center

Movers

UFC, WWE Parent TKO Group Reports Q1 Earnings, Raises FY25 Guidance, Shares Swing Higher

Seaport Research Partners analyst John Mazzoni initiated coverage on several major waste management <a target="_blank" href="https://www.benzinga.com/analyst-ratings/analyst-color" rel="noreferrer noopener">companies with a Buy rating</a>.
The analyst writes that Environmental Services companies present a compelling investment case due to their resilient business models, dependable recurring revenue, and significant barriers to entry.
Historically, this sector has outperformed the S&amp;P 500 by an average of approximately 10% across the past 16 market corrections, with an impressive success rate of around 75%, adds the analyst.
GFL Environmental Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GFL#NYSE">GFL</a>): The analyst initiated coverage with <a target="_blank" href="https://www.benzinga.com/quote/GFL/analyst-ratings" rel="noreferrer noopener">a price forecast of $58</a>.
Mazzoni writes that the company is led by Founder and CEO Patrick Dovigi, who, at 45, is the youngest CEO within the coverage.
This offers the benefit of potential long-term leadership continuity, mitigating succession risks, adds the analyst.
Also Read: <a target="_blank" href="https://www.benzinga.com/25/01/42842877/breaking-ground-gfl-sells-environmental-services-arm-in-landmark-8-b-illiondeal" rel="noreferrer noopener">GFL Environmental To Sell Stake In Environmental Services Business: Debt Reduction &amp; Stock Buyback On The Cards</a>
Further, Mazzoni says that founder-led companies often exhibit more aggressive growth strategies and tend to outperform those led by non-founders, suggesting a potential advantage for GFL.
On May 1, the company reported a first-quarter EPS of $(0.06), which fell short of the $0.04 estimate and sales of $1.09 billion, <a target="_blank" href="https://www.benzinga.com/pressreleases/25/04/n45116486/gfl-environmental-reports-first-quarter-2025-results" rel="noreferrer noopener">exceeded the estimated $1.07 billion</a>.
Republic Services, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RSG#NYSE">RSG</a>): Mazzoni started coverage with a <a target="_blank" href="https://www.benzinga.com/quote/rsg/analyst-ratings" rel="noreferrer noopener">price forecast of $270</a>.
The analyst says that stock performance has significantly improved under the leadership of Jon Vander Ark (JVA), who assumed the CEO role in 2021 after serving as COO since 2018.
The analyst writes that their market analysis indicates that Republic Services currently captures less than 10% of the substantial Environmental Services Total Addressable Market (TAM).
Mazzoni anticipates that technology will play a key role in driving further margin expansion within the Environmental Services sector.
This is expected to be achieved through advancements in areas such as optimized routing, automated notifications, dynamic scheduling, enhanced self-service options for customers, improved collection efficiency, and ultimately, greater customer lifetime value resulting from increased service quality, adds the analyst.
On April 25, the company reported first-quarter adjusted EPS of $1.58, which surpassed the consensus estimate of $1.53 and sales of $4.01 billion, <a target="_blank" href="https://www.benzinga.com/pressreleases/25/04/n44995158/republic-services-inc-reports-first-quarter-2025-results" rel="noreferrer noopener">slightly missing the estimated $4.05 billion</a>.
Waste Connections, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WCN#NYSE">WCN</a>): The analyst initiated coverage <a target="_blank" href="https://www.benzinga.com/quote/wcn/analyst-ratings" rel="noreferrer noopener">with a $220 price forecast</a>.
The company has historically been recognized as the top operator in the Environmental Services industry and currently holds the third-largest market share, says the analyst.
The analyst adds that the stock experienced a decline following an unforeseen event at the Chiquita Canyon landfill (ETLF).
Nevertheless, Mazzoni writes that the positive development is the landfill&#8217;s closure in January 2025, which he believes will lead to decreasing headwinds on free cash flow (FCF) moving forward.
The analyst sees a potential mergers and acquisitions (M&amp;A) pipeline of approximately $4 billion to $5 billion that aligns well with Waste Connections&#8217; existing operations, primarily concentrated in the solid waste sector.
On April 24, the company reported first-quarter adjusted EPS of $1.13, which exceeded the consensus estimate of $1.10 and sales reached $2.23 billion <a target="_blank" href="https://www.benzinga.com/pressreleases/25/04/n44964164/waste-connections-reports-first-quarter-2025-results" rel="noreferrer noopener">beating the estimated $2.22 billion</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/content/45183597/analysts-see-4-000-gold-3-ways-to-invest-at-varied-risk-levels" target="_blank" rel="noreferrer noopener">Analysts See $4,000 Gold: 3 Ways to Invest at Varied Risk Levels</a></li>
</ul>
Photo by BCFC via Shutterstock

Analyst Color

Equities

Large Cap

Mid Cap

Price Target

Initiation

Analyst Ratings

In A Recession, These Waste Management Stocks Have Outperformed S&P500 Historically

BKV Corporation ("BKV" or the "Company") (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BKV#NYSE">BKV</a>) today announced the formation of a strategic joint venture (the "JV") between BKV dCarbon Ventures, LLC ("dCarbon Ventures"), BKV's wholly-owned subsidiary, and Copenhagen Infrastructure Partners ("CIP"), on behalf of its Energy Transition Fund I, to expand BKV's portfolio of carbon capture, utilization and sequestration ("CCUS") projects.
CIP, on behalf of its Energy Transition Fund I, has agreed to commit $500 million to be invested by the JV for use in designing, constructing and operating CCUS projects across the United States in exchange for up to a 49% interest in the JV. BKV has contributed to the JV its ownership of the Barnett Zero and Eagle Ford projects, and has committed to future contributions of CCUS projects, related assets and/or cash, in exchange for a 51% interest in the JV.
The JV will leverage BKV's standing as an early leader in developing CCUS projects while benefitting from CIP's significant experience in developing low-carbon infrastructure projects. BKV and CIP expect to identify investment-ready projects for development by the JV, with BKV serving as the operator of all of the JV's CCUS projects.

Contracts

BKV Forms $500M Joint Venture With Copenhagen Infrastructure Partners To Accelerate U.S. Carbon Capture Projects, Contributing Barnett Zero And Eagle Ford Assets For 51% Stake While CIP Takes Up To 49%

Press Releases

Vivani Medical Achieves First Implant and Full Enrollment in the First-in-Human Clinical Trial of GLP-1 Implant NPM-115 in Obese or Overweight Adults

Vivani Medical to Present at the Emerging Growth Conference on March 27, 2025

Presenting on the Emerging Growth Conference 80, Day 1 on March 26 - Register Now

Presenting on the Emerging Growth Conference 80 Day 2 on March 27 Register Now

Vivani Medical Announces Positive Preclinical Weight Loss Data for NPM-139 Semaglutide Implant, with Potential for Once-Yearly Dosing

Financing

Vivani Medical Announces $8.25M Private Placement Equity Financing

Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results

Vivani Medical and Okava Expand Collaboration to Develop OKV-119 for Dogs, Targeting Metabolic Health and Longevity

Vivani Medical to Participate in Virtual Fireside Chat Hosted by H.C. Wainwright & Company

Vivani Medical to Present at the American Association of Pharmaceutical Scientists' "Beyond GLP1s: Where the Science will Take Business Next" Virtual Workshop

AEMD

ASPI

ATCH

BIXT

BNRG

CSE:HG

CSE:PMC

EGYF

GOVX

HDRSF

HGRAF

IPWR

JAGX

NCSM

NZAUF

PLAB

PMCCF

RGBP

TSX:VGZ

TSXV:HI

TSXV:RUA

VANI

Apyx Medical

HeartBeam

BioSig Technologies

Envoy Medical, Inc. - Class A Common Stock

Envoy Medical

CytoSorbents

Daxor

electroCore

EDAP TMS S.A. - American Depositary Shares, each representing One Ordinary Share

Comments

Vivani Medical

ニュース

最新ニュース Vivani Medical (NASDAQ:VANI) 株価情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル